Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
NUVB
NUVB News & Events
-
Add to Watchlist
Trade NUVB
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
NUVB News
Nuvation Bio (NUVB) Shares Hit Oversold Territory with RSI at 29.5
Jan 12 2026
NASDAQ.COM
Seeking Alpha Releases Q4 Stock Ratings, Micron and Others Rated Strong Buy
Jan 12 2026
seekingalpha
Nuvation Bio (NUVB) Reports $15.7M Q4 Revenue and $25M Milestone Payment from Nippon Kayaku
Jan 12 2026
seekingalpha
Nuvation Bio and Eisai Sign Exclusive Collaboration, Securing $60 Million Upfront Payment
Jan 12 2026
Businesswire
Nuvation Bio and Eisai Form Strategic Collaboration to Expand Taletrectinib's Global Reach
Jan 12 2026
Newsfilter
Nuvation Bio (NUVB): Reevaluating Valuation Following a 78% Increase in Share Price Over the Past Month
Dec 17 2025
Yahoo Finance
Nuvation Bio (NUVB) Receives Upgrade to Buy: Key Information You Need to Know
Dec 15 2025
NASDAQ.COM
Innovent's Seven Innovative Drugs Included in 2025 NRDL
Dec 07 2025
PRnewswire
Show More News
NUVB Events
01/12 10:10
Nuvation Bio Shares Drop 17.3% to $6.65
Nuvation Bio is down -17.3%, or -$1.39 to $6.65.
Show More Events
NUVB Monitor News
Nuvation Bio hits 20-day low amid sector rotation
Jan 23 2026
Nuvation Bio Secures $60 Million from Eisai for Taletrectinib Collaboration
Jan 12 2026
Nuvation Bio Inc. declines amid market weakness
Dec 29 2025
Nuvation Bio stock rises after upgrade to Buy
Dec 19 2025
Nuvation Bio upgraded to Buy amid strong earnings estimates
Dec 18 2025
Nuvation Bio Inc. rises amid market decline
Dec 11 2025
Nuvation Bio Inc stock declines after recent Phase 2 results.
Dec 09 2025
Nuvation Bio Inc. Stock Surges After Positive Trial Results
Dec 05 2025
Show More Monitor News
NUVB Earnings Analysis
No Data
People Also Watch
